Sawada; Yuki
Patent Applications and Registrations
Patent applications and USPTO patent grants for Sawada; Yuki.The latest application filed is for "bicyclic nitrogen-containing aromatic heterocyclic amide compound".
- Sawada; Yuki - Tokyo JP
- Sawada; Yuki - Osaka JP
- Sawada; Yuki - Osaka-shi JP
- Sawada, Yuki - Ushiku-shi JP
- Sawada; Yuki - Ushiku JP
- Sawada; Yuki - Tsukuba JP
| Patent | Date |
|---|---|
| Bicyclic nitrogen-containing aromatic heterocyclic amide compound Grant 9,428,501 - Ohnuki , et al. August 30, 2 | 2016-08-30 |
| Bicyclic Nitrogen-containing Aromatic Heterocyclic Amide Compound App 20150266869 - Ohnuki; Kei ; et al. | 2015-09-24 |
| Quinolone derivative Grant 8,367,702 - Onda , et al. February 5, 2 | 2013-02-05 |
| Quinolone Derivative App 20100256113 - Onda; Kenichi ; et al. | 2010-10-07 |
| Personal Authentication System App 20100217594 - SAWADA; Yuki ; et al. | 2010-08-26 |
| HDAC inhibitor Grant 7,557,127 - Ishibashi , et al. July 7, 2 | 2009-07-07 |
| Hdac Inhibitor App 20090054464 - ISHIBASHI; Naoki ; et al. | 2009-02-26 |
| HDAC inhibitor Grant 7,465,731 - Ishibashi , et al. December 16, 2 | 2008-12-16 |
| Pyrrolopyridazine derivatives Grant 7,317,009 - Abe , et al. January 8, 2 | 2008-01-08 |
| 2-cyanopyrrolidinecarboxamide compound Grant 7,186,731 - Shima , et al. March 6, 2 | 2007-03-06 |
| Pyrrolopyridazine derivatives Grant 7,153,854 - Abe , et al. December 26, 2 | 2006-12-26 |
| Pyrrolopyridazine derivatives App 20060270678 - Abe; Yoshito ; et al. | 2006-11-30 |
| HDAC inhibitor App 20060052599 - Ishibashi; Naoki ; et al. | 2006-03-09 |
| Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors Grant 6,967,197 - Neya , et al. November 22, 2 | 2005-11-22 |
| 2-Cyanopyrrolidinecarboxamide compound App 20050137224 - Shima, Ichiro ; et al. | 2005-06-23 |
| Pyrrolopyridazine derivatives App 20050075342 - Abe, Yoshito ; et al. | 2005-04-07 |
| Inhibitor of cox App 20040157891 - Yamamoto, Hirofumi ; et al. | 2004-08-12 |
| Thiazepinyl hydroxamic acid derivatives as matrix metalloproteinase inhibitors App 20030134849 - Neya, Masahiro ; et al. | 2003-07-17 |
| Imidazopyridinone derivatives and their use as phosphodiesterase inhibitors Grant 6,582,351 - Sawada , et al. June 24, 2 | 2003-06-24 |
| Anthranilic acid derivatives as inhibitors of the CGMP-phosphodiesterase App 20020193614 - Oku, Teruo ; et al. | 2002-12-19 |
| Benzamide derivatives having a vasopressin antagonistic activity Grant 6,316,482 - Setoi , et al. November 13, 2 | 2001-11-13 |
| Benzamide derivatives having a vasopressin antagonistic activity Grant 6,207,693 - Setoi , et al. March 27, 2 | 2001-03-27 |
| Benzimidazole derivatives as bradykinin agonists Grant 6,127,389 - Oku , et al. October 3, 2 | 2000-10-03 |
| Heterocyclic compounds as bradykinin antagonists Grant 6,100,284 - Oku , et al. August 8, 2 | 2000-08-08 |
| Heterocyclic compounds as bradykinin antagonists Grant 6,008,229 - Oku , et al. December 28, 1 | 1999-12-28 |
| Method of preparing certain 3-halo-imidazopyridines Grant 5,750,699 - Oku , et al. May 12, 1 | 1998-05-12 |
| Heterocyclic compounds Grant 5,708,173 - Oku , et al. January 13, 1 | 1998-01-13 |
| Imidazo [1,2-a] pyridines and their pharmaceutical use Grant 5,574,042 - Oku , et al. November 12, 1 | 1996-11-12 |
| Bradykinin antagonist quinolines Grant 5,563,162 - Oku , et al. October 8, 1 | 1996-10-08 |
| Angiotenin II antagonizing heterocyclic compounds Grant 5,354,759 - Oku , et al. October 11, 1 | 1994-10-11 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 